micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Aboutpregnantwomanemergencyclinicalcase
● This template contains an assortment of complementary infographic resources for the
Pregnant woman emergency clinical case
● These infographics are adapted to the style of the aforementioned presentation, so you can
insert them easily and have them completely integrated at once. You just need to do the
following:
○ Select the element that you want to copy
○ Right-click and choose “Copy”
○ Go to the slide where you want the element to appear
○ Right-click and choose “Paste”
4. Pregnantwomanemergencyclinicalcaseinfographics
7months
Jupiter is the biggest
planet of them all
8months
Saturn is a gas giant and
has several rings
9months
Mercury is the smallest
planet of them all
5months
Neptune is the farthest
planet from the Sun
3months
Mars is actually a cold
place, not hot
1month
Venus is the second
planet from the Sun
6. Pregnantwomanemergencyclinicalcaseinfographics
First trimester Secondtrimester Third trimester
1
month
2
month
3
month
4
month
5
month
6
month
7
month
8
month
9
month
Mercury is the closest planet to the
Sun and the smallest one
Venus has a beautiful name and is
the second planet from the Sun
Mars is actually a cold place. It’s full
of iron oxide dust
Neptune is the fourth-largest planet
by diameter in the Solar System
Jupiter is a gas giant and the biggest
planet in the Solar System
Saturn is a gas giant with rings. It’s
composed of hydrogen and helium
9. Pregnantwomanemergencyclinicalcaseinfographics
Mercury
Mercury is the closest planet to the Sun
and the smallest one
Neptune
It's the fourth-largest planet by diameter
in the Solar System
Venus
Venus has a beautiful name and is the
second planet from the Sun
Jupiter
Jupiter is a gas giant and the biggest
planet in the Solar System
10. Pregnantwomanemergencyclinicalcaseinfographics
Follow the link in the graph to modify its data and then paste the new one here. For more info, click here
Week1
Jupiter is the biggest
planet of them all
Week4
Neptune is far away
from Earth
Week3
Mars is actually a cold
place, not hot
Week2
Venus is the second
planet from the Sun
12. Pregnantwomanemergencyclinicalcaseinfographics
Venus
Venus has a beautiful name and is
the second planet from the Sun
Neptune
It's the fourth-largest planet by
diameter in the Solar System
Mercury is the closest planet to the Sun
Mercury 30%
Jupiter is a gas giant and the biggest planet
Jupiter 70%
13. Pregnantwomanemergencyclinicalcaseinfographics
1month
Venus has a
beautiful name
2month
Jupiter is the
biggest planet
3month
Saturn is the
ringed planet
4month
Mercury is the
smallest planet
5month
Neptune is far
away from us
6month
Mars is a cold
place, not hot
7month
Earth is where
we all live on
8month
The Moon is a
natural satellite
9month
Pluto is a
dwarf planet
Weeks
1
2
3
4
5
6
7
8
9
10
11
12
13
14
1sttrimester Weeks
14
15
16
17
18
19
20
21
22
23
24
25
26
27
2nd trimester Weeks
27
28
29
30
31
32
33
34
35
36
37
38
39
40
3rdtrimester
15. Pregnantwomanemergencyclinicalcaseinfographics
75%
Jupiter is the biggest
planet of them all
50%
Saturn is a gas giant
and has several rings
25%
Saturn is a gas giant
with several rings Earth
Earth is the third planet
from the Sun and where
we all live on
15%
Neptune
It's the fourth-largest planet by
diameter in the Solar System
27. Pregnantwomanemergencyclinicalcaseinfographics
Venus
Venus is the second
planet from the Sun
80%
Jupiter
Jupiter is a gas giant
and the biggest planet
50%
Mercury
Mercury is the closest
planet to the Sun
75%
Mars
Mars is actually a very
cold place, not hot
25%
28. Pregnant woman emergency
Mercury Jupiter
Jupiter is a gas giant and
the biggest planet
Mars is actually a very
cold place, not hot
Venus is the second
planet from the Sun
Mercury is the closest
planet to the Sun
Pregnantwomanemergencyclinicalcaseinfographics
29. Mercury Venus Neptune Jupiter
It’s the closest planet to
the Sun and the smallest
one in the Solar System
Venus has a beautiful name
and is the second planet
from the Sun
It's the fourth-largest
planet by diameter in the
Solar System
Jupiter is a gas giant and
the biggest planet in the
Solar System
Pregnantwomanemergencyclinicalcaseinfographics
31. Instructions for use
For more information about editing slides, please read our FAQs or visit Slidesgo School:
https://slidesgo.com/faqs and https://slidesgo.com/slidesgo-school
If you have a free account, in order to use this template, you must credit Slidesgo in your final presentation. Please refer
to the next slide to read the instructions for premium users.
As a Free user, you are allowed to:
- Modify this template.
- Use it for both personal and commercial projects.
You are not allowed to:
- Sublicense, sell or rent any of Slidesgo Content (or a modified version of Slidesgo Content).
- Distribute Slidesgo Content unless it has been expressly authorized by Slidesgo.
- Include Slidesgo Content in an online or offline database or file.
- Offer Slidesgo templates (or modified versions of Slidesgo templates) for download.
- Acquire the copyright of Slidesgo Content.
32. Instructions for use (premium users)
As a Premium user, you can use this template without attributing Slidesgo.
You are allowed to:
● Modify this template.
● Use it for both personal and commercial purposes.
● Share this template in an editable format with people who are not part of your team.
You are not allowed to:
● Sublicense, sell or rent this Slidesgo Template (or a modified version of this Slidesgo Template).
● Distribute this Slidesgo Template (or a modified version of this Slidesgo Template) or include it in a database or in
any other product or service that offers downloadable images, icons or presentations that may be subject to
distribution or resale.
● Use any of the elements that are part of this Slidesgo Template in an isolated and separated way from this
Template.
● Register any of the elements that are part of this template as a trademark or logo, or register it as a work in an
intellectual property registry or similar.
For more information about editing slides, please read our FAQs or visit Slidesgo School:
https://slidesgo.com/faqs and https://slidesgo.com/slidesgo-school
33. Infographics
You can add and edit some infographics to your presentation to present your data in a visual way.
● Choose your favourite infographic and insert it in your presentation using Ctrl C
+ Ctrl V or Cmd C + Cmd V in Mac.
● Select one of the parts and ungroup it by right-clicking and choosing
“Ungroup”.
● Change the color by clicking on the paint bucket.
● Then resize the element by clicking and dragging one of the square-shaped
points of its bounding box (the cursor should look like a double-headed arrow).
Remember to hold Shift while dragging to keep the proportions.
● Group the elements again by selecting them, right-clicking and choosing
“Group”.
● Repeat the steps above with the other parts and when you’re done editing, copy
the end result and paste it into your presentation.
● Remember to choose the “Keep source formatting” option so that it keeps the
design. For more info, please visit Slidesgo School.
